Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by ganja50on Jul 23, 2015 1:47am
169 Views
Post# 23951598

RE:RE:RE:RE:Cure For Cancer Worth $50 Trillion, Study Says

RE:RE:RE:RE:Cure For Cancer Worth $50 Trillion, Study SaysSo the goons brought in a third leg for the stool.  Must be REALLY concerned you are losing control of the trading.  

We aren't pumper and dumpers.  We own the stock, we think it may make us a fortune, and we're enthusiastic.  It's a bit absurd to call every expression of approval a pump, and every moment of exasperation a dump.   Not everyone is a day trader.  Personally I intend to hold onto this stock for several yrs if necessary to realize the full compliment of gains, and I'm sure many others do as well.

You seem to have lost sight of the fact that this is OUR VILLAGE, not yours.  You are an enemy in our midst that is tolerated so show some respect for the dominant emotion on this board which is enthusiasm.  
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities